4J8-71892-54800
3 vaccinations
2 coded responses
21 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 402 / KY
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Registered in v-safe
-
2021-01-28
Dose 2 — Pfizer-BioNTech
- 2021-01-28
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Headache, Muscle or body achesAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-04-29
-
2021-07-29
Survey response — 6 months, dose 2MedDRA: Neuralgia, Paraesthesia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Nerve type pain, tingling all over my bodyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-29
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-10
-
2021-12-18
Dose 3 — Pfizer-BioNTech
- 2022-01-28
- 2022-01-28
- 2022-01-29
-
2022-03-19
Survey response — 3 months, dose 3MedDRA: Cough, Fatigue, Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: Good · Be unable to work or attend schoolFree text: Congestion, headache, fatigue, sore throat, coughMedDRA releases: 2024-11 · check-in free text available
- 2022-06-18
- 2022-12-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech | |
| 3 | 2021-12-18 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-29 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: Nerve type pain, tingling all over my body
Release 11 — 3 months, dose 3
Symptoms: Congestion, headache, fatigue, sore throat, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Neuralgia | ✓ | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paraesthesia | ✓ | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release